Table 3.

Effectiveness outcomes

Outcome	Follow-up visit at 6 months			Follow-up visit at 12 months
	n	Baseline value	Follow-up value	n	Baseline value	Follow-up value
BOT group
HbA1c (%)	156	8.4 ± 1.2	7.5 ± 1.1***	51	8.4 ± 1.0	7.3 ± 0.9***
HbA1c < 7%, n (%)	157	15 (9.6)	49 (31.2)***	51	2 (3.9)	16 (31.4)***
Weight (kg)	138	93.0 ± 18.8	92.0 ± 18.9*	50	98.0 ± 21.9	96.6 ± 20.4
BMI (kg/m2)	138	33.0 ± 6.3	32.7 ± 6.2*	50	34.4 ± 7.2	33.9 ± 6.5
FPG (mg/dL	103	160.8 ± 48.2	122.8 ± 41.1***	37	139.6 ± 36.5	118.4 ± 34.5***
Lipid profile (mg/dL)
Total cholesterol	104	167.9 ± 43.3	154.1 ± 39.5***	33	161.2 ± 41.9	145.7 ± 33.7**
Triglycerides	102	144.1 ± 82.5	138.3 ± 89.8	33	151.5 ± 72.4	118.5 ± 51.2**
BB
HbA1c (%)	45	8.2 ± 1.3	7.7 ± 1.2**	17	7.6 ± 0.8	7.3 ± 1.1
HbA1c < 7%, n (%)	45	11 (24.4)	15 (33.3)	17	6 (35.3)	7 (41.2)
Weight (kg)	46	103.0 ± 22.9	100.1 ± 22.5***	17	106.3 ± 22.8	100.1 ± 20.8***
BMI (kg/m2)	46	35.9 ± 7.2	35.0 ± 7.1**	17	36.2 ± 7.0	34.1 ± 6.1**
FPG (mg/dL)	38	153.3 ± 50.8	143.1 ± 45.3	15	136.9 ± 29.9	127.5 ± 32.9
Lipid profile (mg/dL)
Total cholesterol	27	169.9 ± 43.9	163.7 ± 39.9	14	168.6 ± 48.8	145.0 ± 25.0
Triglycerides	26	141.0 ± 75.7	153.3 ± 85.3	14	142.3 ± 72.7	154.3 ± 65.0

Values are presented as the mean ± SD, unless indicated otherwise

*p < 0.05, **p < 0.01, ***p < 0.001 versus baseline value